Detection of activated KRAS from cancer patient peripheral blood using a weighted enzymatic chip array

BACKGROUND: The KRAS oncogene was one of the earliest discoveries of genetic alterations in colorectal and lung cancers. Moreover, KRAS somatic mutations might be used for predicting the efficiency of anti-EGFR therapeutic drugs. The purpose of this research was to improve Activating KRAS Detection...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ming-Yii, Liu, Hsueh-Chiao, Yen, Li-Chen, Chang, Jia-Yuan, Huang, Jian-Jhang, Wang, Jaw-Yuan, Hsiao, Chao-Peng, Lin, Shiu-Ru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055935/
https://www.ncbi.nlm.nih.gov/pubmed/24884535
http://dx.doi.org/10.1186/1479-5876-12-147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055935/
https://www.ncbi.nlm.nih.gov/pubmed/24884535
http://dx.doi.org/10.1186/1479-5876-12-147

Ejemplares similares